Stephen Picone
President

Stephen Picone comes to Enzymatics following a 10-year career as a product manager for New England BioLabs. In the lab, Mr. Picone focused his efforts on chromatography process development, manufacture and quality control of a variety of DNA modifying enzymes. Mr. Picone also fostered international business relations through technical training and marketing activities in addition to coordinating NEB's technical service program. His research on the cloning and overexpression of the restriction endonuclease Eae I has been published in the Journal of Biological Chemistry. In 1997 Stephen graduated from the University of Vermont with a B.S. in Microbiology and Molecular Genetics. Stephen received his Masters in Business Administration from Suffolk University in 2003.

Christopher Benoit
Chief Operating Officer

Prior to co-founding Enzymatics, Mr. Benoit served from 1995-2006 as the product manager for DNA polymerases at New England BioLabs. At NEB, Mr. Benoit was instrumental in the design and implementation of product development strategies, manufacturing scale-up, and all aspects of the characterization, quality control, and technical support of the full range of DNA polymerases. Christopher holds a BS in Biochemistry from the University of Massachusetts at Amherst.

Noah Sachs, J.D.
Director of Business Development, General Counsel

From 2001 to 2003 Noah Sachs was an in-house expert in laboratory robotics and multidimensional experimental drug discovery with CombinatoRx Inc. In 2003, he moved to the intellectual property department where he served as the technology specialist and lawyer liaison. He is a co-inventor on over ten patent applications for the treatment of immunoinflammatory disorders. Mr. Sachs received his Juris Doctorate from Suffolk University Law School in 2006. From 1999 to 2001 he was a Research Assistant at New England BioLabs focusing on the design of a selection technique for cloning novel restriction enzyme systems from extremophiles. Mr. Sachs holds a B.S. in molecular biology from The Evergreen State College.

Dr. Richard Whitaker, Ph.D.
Director of Research and Development

Before his appointment as Director of Research at Enzymatics, Rich worked for twelve years at New England Biolabs as a research and product development scientist. His areas of study included restriction endonuclease specificity, optimized protein expression in E. coli, development of DNA modification enzymes into new products, and the design of enzyme activity and quality control assays. Rich received a B.S. in Biochemistry at the University of Illinois in 1989, a M.S. in Food Microbiology at Cornell University in 1991, and a Ph. D. at Cornell University in 1995. His dissertation was on the "Kinetic and Structural Studies of the Streptomyces rubiginosus D-xylose isomerase."